Taking Aim At Recurrence: Targeting Cancer Stem Cells To Stop Proliferation
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
An emerging field of oncology drug development offers the potential for eradicating all remaining cancer cells following treatment – and thus preventing recurrence – by targeting the so-called cancer stem cells that are thought to be involved in cancer proliferation, treatment resistance, and metastasis.